A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Investigational Drug Gaining Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Followers are encouraged to message these accounts privately for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Separately, a flourishing market exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of rapid UK delivery. Vendors promote the drug there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Experts Voice Concerns
Nevertheless, physicians and chemists have cautions that the distribution of what remains an unlicensed drug in the UK is worrisome and could result in users administering products of uncertain source.
Several experts stated the demand for retatrutide could be linked to the rising cost of licensed weight loss products such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the British medical regulations.
Some content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach medicines, marketing, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.
Platform Reaction and Material Removal
According to TikTok, the platform has taken down problematic material and prohibited related keywords and search suggestions. The company said it was dedicated to keeping the service safe and allocating resources in strengthening compliance measures.
Online Trading Activities
Investigations also found communities with up to nine thousand members marketing retatrutide using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, filled with images of slimming results, glowing reviews and detailed guides for preparing or administering at residence.
After minutes of joining one community, a vendor shared contact information, where most purchases take place. The vendor provided an instruction manual and promised shipping within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about body mass, health issues or past usage.
Product Information and Costs
Within these groups, posts show dark colored packages with postal service labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A representative for Telegram said it regularly moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering materials they can’t verify. Although the research behind this drug is valid, these online versions may not contain what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.
A medical professional of an online medical service connected the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said.
Her team has previously encountered patients harmed by personal administration from unverified sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject patients to potentially serious health risks”.
